These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2506609)

  • 1. Blockade of conditioned avoidance responding by trazodone, etoperidone, and MCPP.
    Martin GE; Mathiasen JR; Kesslick JM
    Psychopharmacology (Berl); 1989; 99(1):94-7. PubMed ID: 2506609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Block of conditioned avoidance responding in the rat by substituted phenylpiperazines.
    Martin GE; Elgin RJ; Kesslick JM; Baldy WJ; Mathiasen JR; Shank RP; Scott MK
    Eur J Pharmacol; 1988 Nov; 156(2):223-9. PubMed ID: 3240768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoperidone, trazodone and MCPP: in vitro and in vivo identification of serotonin 5-HT1A (antagonistic) activity.
    Raffa RB; Shank RP; Vaught JL
    Psychopharmacology (Berl); 1992; 108(3):320-6. PubMed ID: 1387963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine.
    Cioli V; Corradino C; Piccinelli D; Rocchi MG; Valeri P
    Pharmacol Res Commun; 1984 Jan; 16(1):85-100. PubMed ID: 6701182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system.
    Przegaliński E; Lewandowska A
    J Neural Transm; 1979; 46(4):303-12. PubMed ID: 529000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of aromatic substituted phenylpiperazines lacking affinity for dopamine binding sites in a preclinical test of antipsychotic efficacy.
    Martin GE; Elgin RJ; Mathiasen JR; Davis CB; Kesslick JM; Baldy WJ; Shank RP; DiStefano DL; Fedde CL; Scott MK
    J Med Chem; 1989 May; 32(5):1052-6. PubMed ID: 2565400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opposite action of m-chlorophenylpiperazine on avoidance depression induced by trazodone and pimozide in CD-1 mice.
    Vetulani J; Sansone M; Baran L; Hano J
    Psychopharmacology (Berl); 1984; 83(2):166-8. PubMed ID: 6431467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
    Fiorella D; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary study of the biotransformation of two new drugs, trazodone and etoperidone.
    Melzacka M; Rurak A; Vetulani J
    Pol J Pharmacol Pharm; 1980; 32(4):551-6. PubMed ID: 7255270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effects.
    Corbin AE; Meltzer LT; Ninteman FW; Wiley JN; Christoffersen CL; Wustrow DJ; Wise LD; Pugsley TA; Heffner TG
    Neuropharmacology; 2000 Apr; 39(7):1211-21. PubMed ID: 10760363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and nonselective serotonin antagonists block the aversive stimulus properties of MK212 and m-chlorophenylpiperazine (mCPP) in mice.
    Walker EA; Kohut SJ; Hass RW; Brown EK; Prabandham A; Lefever T
    Neuropharmacology; 2005 Dec; 49(8):1210-9. PubMed ID: 16165167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine agonists reduce conditioned avoidance responding in the rat.
    Martin GE; Rossi DJ; Jarvis MF
    Pharmacol Biochem Behav; 1993 Aug; 45(4):951-8. PubMed ID: 8105493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trazodone and m-chlorophenylpiperazine. Concentration in brain and receptor activity in regions in the brain associated with anxiety.
    Smith TM; Suckow RF
    Neuropharmacology; 1985 Nov; 24(11):1067-71. PubMed ID: 4080105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of trazodone and m-chlorophenylpiperazine (mCPP) in mice: interaction with morphine.
    Valeri P; Pimpinella G; Morrone LA; Romanelli L
    Gen Pharmacol; 1991; 22(1):127-31. PubMed ID: 2050281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of etoperidone on the depletion of brain 5-hydroxytryptamine and catecholamines induced respectively by p-chloromethamphetamine and 6-hydroxydopamine in rats.
    Carruba MO; Parenti M; Ricciardi S; Picotti GB; Mantegazza P
    Pharmacol Res Commun; 1979 Feb; 11(2):169-77. PubMed ID: 155821
    [No Abstract]   [Full Text] [Related]  

  • 17. Discriminative stimulus properties of mCPP: evidence for a 5-HT2C receptor mode of action.
    Gommans J; Hijzen TH; Maes RA; Olivier B
    Psychopharmacology (Berl); 1998 Jun; 137(3):292-302. PubMed ID: 9683007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of meta-chlorophenylpiperazine (mCPP), a central serotonin agonist and vascular serotonin receptor antagonist, on blood pressure in SHR.
    Cohen ML; Kurz KD; Fuller RW
    Clin Exp Hypertens A; 1987; 9(10):1549-65. PubMed ID: 3677442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of serotonin agonistic and antagonistic activities of a new antidepressant agent Trelibet (EGYT-475) and its metabolite EGYT-2760 on isolated rat fundus.
    Malomvölgyi B; Tóthfalusi L; Tekes K; Magyar K
    Acta Physiol Hung; 1991; 78(3):201-9. PubMed ID: 1814162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of clozapine with the meta-chlorophenylpiperazine (mCPP) discriminative stimulus.
    Fiorella D; Rabin RA; Winter JC
    Life Sci; 1996; 58(24):PL353-8. PubMed ID: 8649203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.